Efficacy of topiramate (Topamax) in epileptic patients of different ages

Neuroscience and Behavioral Physiology

Volumn 37, Issue 6, 2007, Pages 547-551

  Voronkova, K V ^a   Pylaeva, O A ^a   Petrukhin, A S ^a  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Age related characteristics; Epilepsy; Topiramate (Topamax); Treatment

Indexed keywords

TOPIRAMATE;

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; AGED; ARTICLE; CHILD; CHILDHOOD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PARESTHESIA; PUBERTY; REMISSION; SIDE EFFECT; SKIN ALLERGY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGE FACTORS; ANTICONVULSANTS; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548257793     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0051-2     Document Type: Article

References (15)

1. K. Yu. Mukhin, L. Yu. Glukhova, A. S. Petrukhin, et al., "Topamax monotherapy in epilepsy," Zh. Nevrol. Psikhiat., 104, No. 8, 35-40 (2004).
2. A. M. Albsoul-Younes, H. A. Salem, S. F. Ajlouni, and S. A. Al-Safi, "Topiramate slow dose titration: Improved efficacy and tolerability," Pediat. Neurol., 31, No. 5, 349-352 (2004).
3. G. K. Bergey, "Initial treatment of epilepsy: Special issues in treating the elderly," Neurology, 63, No. 10, Supplement 4, 40-48 (2004).
4. G. Coppola, G. Caliendo, M. M. Terracciano, et al., "Topiramate in refractory partial-onset seizures in children, adolescents and young adults: A multicentric open trial," Epilepsy Res., 43, No. 3, 255-260 (2001).
5. R. D. Elterman, The A. Glauser, E. Wyllie, et al., "A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children," Neurology, 52, 1338-1344 (1999).
6. F. G. Gilliam, F. Veloso, M. A. Bonhof, et al., "A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy," Neurology, 60, No. 2, 196-202 (2003).
7. T. A. Glauser, "Preliminary observation on topiramate in pediatric epilepsies," Epilepsia, 38, Supplement 1, 37-41 (1997).
8. M. Goyal, M. A. O'Riordan, and M. Wiznitzer, "Effect of topiramate on seizures and respiratory dysrhythmia in Rett syndrome," J. Child Neurol., 19, No. 8, 588-591 (2004).
9. A. P. Kudin, G. Debska-Vielhaber, S. Vielhaber, et al., "The mechanism of neuroprotection by topiramate in an animal model of epilepsy," Epilepsia, 45, No. 12, 1478-1487 (2004).
10. R. Ormrod and K. McClellan, "Topiramate: A review of its use in childhood epilepsy," Paediat. Drugs, 3, No. 4, 293-319 (2001).
11. M. D. Privitera, M. J. Brodie, R. H. Mattson, et al., "Topiramate, carbamazepine and valproate monotherapy: Double-blind comparison in newly diagnosed epilepsy," Acta Neurol. Scand., 107, No. 3, 165-175 (2003).
12. W. E. Rosenfield, R. C. Sachedo, et al., "Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: Retrospective survey of open-label treatment," Epilepsia, 38, Supplement 1, 34-36 (1997).
13. R. C. Sachedo, R. Patell, and K. U. Rehnam, "Long-term experience with topiramate monotherapy," Epilepsia, 38, No. 3, 294-300 (1997).
14. C. A. Tassinari et al., "Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy," Epilepsia, 37, 763-768 (1996).
15. J. W. Wheless, W. Neto, and S. Wang, "Topiramate, carbamazepine, and valproate in children with newly diagnosed epilepsy: A unique trial design," Neurology, 56, Supplement 3 (2001).